This research explores treatment options for low-grade serous ovarian cancer, highlighting the need for effective non-chemotherapy regimens. High-grade serous ovarian cancer remains a primary focus in ...

First, ensure you have the necessary tools installed on your computer. You’ll need Node.js and npm since they are required for CDK. Also, install Python 3.x and the ...

CDK, the leading automotive retail software provider, today announced the launch of its Customer Data Platform (CDP)that unifies fragmented customer information and delivers real-time, actionable ...

A new and important discovery comes from the field of oncological research thanks to the joint work of researchers from the Sbarro Institute in Philadelphia, the National Cancer Institute – Pascale ...

This discussion has been edited for length and clarity. Three clinicians explore the headline-making evidence from the monarchE and NATALEE trials presented at the 2025 ESMO Congress. Laura A. Huppert ...

A federal judge in Chicago allowed the insurer of two auto dealership groups to pursue breach of contract claims arising from the summer 2024 CDK Global cyberattacks. However, U.S. District Judge ...

In a phase 3 trial-based cost-effectiveness analysis for advanced breast cancer, treatment with cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors in the second line rather than the first line ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

CDK Global LLC, a provider of cloud-based software for auto dealerships and original equipment manufacturers, has launched SimplePay, a cloud-based payments solution for auto dealers. Austin, ...

A $4 billion term loan issued by CDK Global slipped into distressed territory last week after a federal judge ruled that a rival’s lawsuit could move ahead against the maker of software for auto ...

With an estimated 1.5 million new cases and 397,000 deaths worldwide, prostate cancer is the world's second most frequent cancer and the fifth leading cause of cancer death among men in 2022. Hormone ...